Capecitabine with radiation is an effective adjuvant therapy in gastric cancers

doi:10.3748/wjg.v16.i29.3709

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3927)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

309

HTML

3310

Figures (1-1)

158

Tables (1-4)

150

Sum=3927

Aug 7, 2010 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 7, 2010; 16(29): 3709-3715
Published online Aug 7, 2010. doi: 10.3748/wjg.v16.i29.3709

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier estimates. A: Recurrence-free survival of capecitabine + radiation (XRT), 5-fluorouracil + radiation (5FU-RT) and chemotherapy alone; B: Overall Survival of XRT, 5FU-RT and chemotherapy alone; C: Recurrence-free survival of RT-containing regimen vs chemotherapy alone; D: Overall survival of RT-containing regimen vs chemotherapy alone.

Citation: Tham CK, Choo SP, Poon DYH, Toh HC, Ong SYK, Tan SH, Wang MLC, Foo KF. Capecitabine with radiation is an effective adjuvant therapy in gastric cancers. World J Gastroenterol 2010; 16(29): 3709-3715
URL: https://www.wjgnet.com/1007-9327/full/v16/i29/3709.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i29.3709